The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)
Advanced Search

Session Details

Oral Presentation(C) Pharmaceutical Biology

[28-10-am]Virology

Fri. Mar 28, 2025 4:25 PM - 6:01 PM JST
Fri. Mar 28, 2025 7:25 AM - 9:01 AM UTC
Room 10 (Fukuoka International Congress Center: 412 [4F])
Chair: Itsuki Anzai, Shuzo Urata
4:25 PM - 4:37 PM JST(7:25 AM - 7:37 AM UTC)

[28-10-pm07]Broad-spectrum antiviral RNA oligomers with G-quadruplex (G4 structure) and their antiviral activity

○Shusuke Kuge1, Kouki Takeda1 (1. Faculty of Pharm. Sci., Tohoku Med. Pharm. Univ.)
4:37 PM - 4:49 PM JST(7:37 AM - 7:49 AM UTC)

[28-10-pm08]Analysis of elevation and function of CCL20 chemokine in colorectal cancer cell lines infected with human cytomegalovirus

○Reina Kawaguchi1, Yuiri Higa1, Tohru Daikoku1, Masaya Takemoto1 (1. Hokuriku University)
4:49 PM - 5:01 PM JST(7:49 AM - 8:01 AM UTC)

[28-10-pm09]Analysis of infectivity of alpha-herpesviruses in human iPSC-derived motor neurons

○Sara Ishimaru1, Haruna Suzuki1, Tohru Daikoku1, Masaya Takemoto1 (1. Hokuriku University)
5:01 PM - 5:13 PM JST(8:01 AM - 8:13 AM UTC)

[28-10-pm10S]Functional elucidation of the KSHV terminase complex

○Yuki Iwaisako1, Tadashi Watanabe2, Youichi Suzuki3, Takashi Nakano3, Masahiro Fujimuro1 (1. Kyoto Pharm. Univ., 2. Univ. of the Ryukyus, 3. Osaka Med. and Pharm. Univ.)
5:13 PM - 5:25 PM JST(8:13 AM - 8:25 AM UTC)

[28-10-pm11]Research on maternal immune status related to acquired CMV infection

Keita Takahashi1, Juri Koizumi1, Yuka Torii2, Yuichiro Sugiyama3, ○Tetsuo Koshizuka1 (1. Gifu Pharmaceutical University, 2. Nagoya University Hospital, 3. Japanese Red Cross Medical Center Nagoya Daiichi Hospital)
5:25 PM - 5:37 PM JST(8:25 AM - 8:37 AM UTC)

[28-10-pm12S]Mechanism of attenuation of vaccine efficacy via type I IFN signaling by intranasally administered adenovirus vectors

○Hayato Nakatani1, Masashi Tachibana1,2, Rika Onishi1, Kahori Shimizu1, Fuminori Sakurai1,3, Hiroyuki Mizuguchi1,4,5,6,7 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. Col. Life. Sci., Ritsumeikan Univ., 3. Sch. of Pharm. Sci., Kindai Univ., 4. NIBIOHN, 5. MEI cent., 6. OTRI, 7. CiDER, Osaka Univ.)
5:37 PM - 5:49 PM JST(8:37 AM - 8:49 AM UTC)

[28-10-pm13S]Development of anti-viral coating by disinfectant filled porous AD coating

○Kazuho Fujiwara1, Hisato Kato1, Taku Goto2, Keisuke Yoshii1, Mutsumi Shiyama3, Takeji Ueda1, Mitsugu Soma2, Kenichi Shimada1, Sumiko Shiota1, Takako Nakamura2, Wakano Ogawa1, Nobuhiro Ohtsuka3, Jun Akedo2, Yoichi Yamada1 (1. Sch. Pharm., Shujitsu Univ., 2. Nat. I., Advanced Ind. Sci. Tech., 3. Nogata City.)
5:49 PM - 6:01 PM JST(8:49 AM - 9:01 AM UTC)

[28-10-pm14S]Development of a new anti-influenza drug using host factor-targeted antisense oligonucleotides

○Makoto Shimooka1, Tomomi Kirino1, Harumi Yamaguma2, Hina Miyazaki1, Itsuki Anzai1,3, Shintaro Shichinohe1, Satoshi Obika3,4,5,6, Yuuya Kasahara2,5, Tokiko Watanabe1,3,4 (1. RIMD, Osaka Univ., 2. NIBIOHN, 3. CiDER, 4. CAMaD, 5. Grad. Sch. Pharm. Sci., Osaka Univ., 6. OTRI, Osaka Univ.)
Back to Category List